Search Results - "Zonova, Elena"

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study by Nasonov, Evgeniy, Fatenejad, Saeed, Feist, Eugen, Ivanova, Mariana, Korneva, Elena, Krechikova, Diana G, Maslyanskiy, Aleksey L, Samsonov, Mikhail, Stoilov, Rumen, Zonova, Elena V, Genovese, Mark

“…To evaluate the efficacy and safety of olokizumab (OKZ) in patients with active rheumatoid arthritis despite treatment with methotrexate (MTX). In this 24-week…”
Get more information

Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel by Mazurov, Vadim I., Alekseeva, Liudmila I., Belyaeva, Irina B., Belenkiy, Igor G., Burulev, Artem L., Gaydukova, Inna Z., Zonova, Elena V., Kalyuzhin, Oleg V., Nesmeyanova, Olga B., Otteva, Elvira N., Trofimov, Evgeniy A.

“…A meeting of the Expert Council on September 9, 2023 considered the last challenges in the treatment of osteoarthritis (OA) including OA in comorbid patients…”
Get full text

Results of a clinical study of Traumeel® S and Zeel® T in patients with knee osteoarthritis and concomitant cardiovascular disease by Alekseeva, L. I., Mazurov, V. I., Zonova, E. V., Ershova, O. B., Reshetko, O. V.

“…   Objective:  to evaluate the efficacy and safety of simultaneous intramuscular administration of Traumeel® S and Zeel® T followed by therapy with the tablet…”
Get full text

Resolution of the Council of Experts of May 20, 2023 "Issues of safety in the treatment of a rheumatological patient" by Alekseeva, L. I., Anoshenkova, O. N., Dolganova, N. G., Zholobova, E. S., Zonova, E. V., Lapshina, S. A., Korolev, M. A., Menshikova, L. V., Shesternya, P. A., Chasovskikh, Yu. P.

“…At the meeting of the Expert Council on May 20, the safety of treatment for patients with osteoarthritis (OA), the most common form of joint disease, was…”
Get full text

Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis by Konenkov, V I, Zonova, E V, Korolev, M A, Leonova, Iu B, Shevchenko, A V, Golovanova, O V, Prokof'ev, V F

“…To analyze the prognostic value of detection of allelic variants of the promoter regions of cytokine genes in patients with rheumatoid arthritis (RA) with…”
Get full text